pharma news today obesity glp-1 agonists and changes in body mass and composition in adults with overweight or with or without type 2 diabetes mellitus: a systematic review and meta-analysis glp-1 latest analogs, new trend

Lin AW, Barradas M, Stone JC, van Aelst L, Serrano M, Lowe SW

HRP-conjugated secondary antibodies (rabbit IgG: 111035144, mouse IgG: 115035003, 1:3000 dilution in 3% BSA, Jackson ImmunoResearch) and the ECL-2 (Thermo Scientific) or ECL (GE Amersham) chemiluminescent reagent were used to visualize the bands using a Bio-Rad ChemiDoc imaging system running Image Lab V4.0 software

Full recovery to baseline GH pulse amplitude takes 14-21 days with a taper protocol versus 21-28 days with cold-turkey cessation, based on GHRH receptor upregulation timelines

GDNF-expressing macrophages restore motor functions at a severe late-stage, and produce long-term neuroprotective effects at an early-stage of Parkinsons disease in transgenic Parkin Q311X(A) mice